These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Brain endogenous angiotensin II receptor type 2 (AT2-R) protects against DOCA/salt-induced hypertension in female rats. Dai SY; Peng W; Zhang YP; Li JD; Shen Y; Sun XF J Neuroinflammation; 2015 Mar; 12():47. PubMed ID: 25885968 [TBL] [Abstract][Full Text] [Related]
4. Blockade of angiotensin receptors in the anterior hypothalamic preoptic area lowers blood pressure in DOCA-salt hypertensive rats. Kubo T; Yamaguchi H; Tsujimura M; Hagiwara Y; Fukumori R Hypertens Res; 2000 Mar; 23(2):109-18. PubMed ID: 10770257 [TBL] [Abstract][Full Text] [Related]
5. Intracerebroventricular infusion of the (Pro)renin receptor antagonist PRO20 attenuates deoxycorticosterone acetate-salt-induced hypertension. Li W; Sullivan MN; Zhang S; Worker CJ; Xiong Z; Speth RC; Feng Y Hypertension; 2015 Feb; 65(2):352-61. PubMed ID: 25421983 [TBL] [Abstract][Full Text] [Related]
6. Effects of salt and DOCA on hypothalamic and baroreflex control of blood pressure. Takeda K; Nakamura Y; Hayashi J; Kawasaki S; Nakata T; Oguro M; Sasaki S; Nakagawa M Clin Exp Hypertens A; 1988; 10 Suppl 1():289-99. PubMed ID: 3242995 [TBL] [Abstract][Full Text] [Related]
7. Effects of centrally administered losartan on deoxycorticosterone-salt hypertension rats. Park CG; Leenen FH J Korean Med Sci; 2001 Oct; 16(5):553-7. PubMed ID: 11641522 [TBL] [Abstract][Full Text] [Related]
8. Central renin-angiotensin system and the pathogenesis of DOCA-salt hypertension in rats. Itaya Y; Suzuki H; Matsukawa S; Kondo K; Saruta T Am J Physiol; 1986 Aug; 251(2 Pt 2):H261-8. PubMed ID: 3526927 [TBL] [Abstract][Full Text] [Related]
9. Angiotensinergic signaling in the brain mediates metabolic effects of deoxycorticosterone (DOCA)-salt in C57 mice. Grobe JL; Buehrer BA; Hilzendeger AM; Liu X; Davis DR; Xu D; Sigmund CD Hypertension; 2011 Mar; 57(3):600-7. PubMed ID: 21263123 [TBL] [Abstract][Full Text] [Related]
10. Role of angiotensin II in cerebrovascular and renal damage in deoxycorticosterone acetate-salt hypertensive rats. Wada T; Kanagawa R; Ishimura Y; Inada Y; Nishikawa K J Hypertens; 1995 Jan; 13(1):113-22. PubMed ID: 7759841 [TBL] [Abstract][Full Text] [Related]
11. Central attenuation of aortic baroreceptor reflex in prehypertensive DOCA-salt-loaded rats. Nakamura Y; Takeda K; Nakata T; Hayashi J; Kawasaki S; Lee LC; Sasaki S; Nakagawa M; Ijichi H Hypertension; 1988 Sep; 12(3):259-66. PubMed ID: 3169941 [TBL] [Abstract][Full Text] [Related]
12. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats. Schiffrin EL; Turgeon A; Deng LY Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550 [TBL] [Abstract][Full Text] [Related]
13. L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats. Toba H; Yoshida M; Tojo C; Nakano A; Oshima Y; Kojima Y; Noda K; Wang J; Kobara M; Nakata T Hypertens Res; 2011 Apr; 34(4):521-9. PubMed ID: 21270815 [TBL] [Abstract][Full Text] [Related]
14. Diosmin, a bioflavonoid reverses alterations in blood pressure, nitric oxide, lipid peroxides and antioxidant status in DOCA-salt induced hypertensive rats. Silambarasan T; Raja B Eur J Pharmacol; 2012 Mar; 679(1-3):81-9. PubMed ID: 22266490 [TBL] [Abstract][Full Text] [Related]
15. Attenuation of cardiovascular remodeling in DOCA-salt rats by the vasopeptidase inhibitor, omapatrilat. Loch D; Hoey A; Brown L Clin Exp Hypertens; 2006 Jul; 28(5):475-88. PubMed ID: 16820344 [TBL] [Abstract][Full Text] [Related]
17. Consistent antioxidant and antihypertensive effects of oral sodium nitrite in DOCA-salt hypertension. Amaral JH; Ferreira GC; Pinheiro LC; Montenegro MF; Tanus-Santos JE Redox Biol; 2015 Aug; 5():340-346. PubMed ID: 26119848 [TBL] [Abstract][Full Text] [Related]
18. Central attenuation of baroreflex precedes the development of hypertension in DOCA-salt-treated rats. Takeda K; Nakamura Y; Oguro M; Kawasaki S; Hayashi J; Tanabe S; Nakata T; Lee LC; Sasaki S; Nakagawa M Am J Hypertens; 1988 Jul; 1(3 Pt 3):23S-25S. PubMed ID: 3415800 [TBL] [Abstract][Full Text] [Related]
19. Effect of myricetin on deoxycorticosterone acetate (DOCA)-salt-hypertensive rats. Borde P; Mohan M; Kasture S Nat Prod Res; 2011 Sep; 25(16):1549-59. PubMed ID: 21391110 [TBL] [Abstract][Full Text] [Related]
20. β-Arrestin-Biased Agonist Targeting the Brain AT Zanaty M; Seara FAC; Nakagawa P; Deng G; Mathieu NM; Balapattabi K; Karnik SS; Grobe JL; Sigmund CD Hypertension; 2021 Feb; 77(2):420-431. PubMed ID: 33249862 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]